RocketTickers

RocketTickers

ERAS: Erasca, Inc. 2021-12-17 08:00:00 Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial

RocketTickers

TVTX: Travere Therapeutics, Inc. 2021-12-15 07:00:00 Travere Therapeutics Announces Positive Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria

RocketTickers

NUVB: Nuvation Bio Inc. 2021-12-13 07:00:00 Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Prostate Cancer

RocketTickers

CHRS: Junshi Biosciences 2021-12-13 07:00:00 Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

RocketTickers

AUPH: Aurinia Pharmaceuticals Inc. 2021-12-09 06:15:00 Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)

RocketTickers

2021-12-07 07:00:00 Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

RocketTickers

AMGN: Amgen Inc. 2021-12-01 16:00:00 Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis

RocketTickers

VRTX: Vertex Pharmaceuticals Incorporated 2021-12-01 07:30:00 Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis

RocketTickers

MRNA: Moderna, Inc. 2021-11-15 08:35:00 Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery

RocketTickers

CHRS: Coherus BioSciences, Inc. 2021-11-15 08:30:00 Coherus and Junshi Biosciences Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer

RocketTickers

PRLD: Prelude Therapeutics Incorporated 2021-11-08 09:00:00 Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor

RocketTickers

SEEL: Seelos Therapeutics, Inc. 2021-11-08 08:00:00 Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia

RocketTickers

TMDX: TransMedics Group, Inc. 2021-11-04 07:00:00 TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial

RocketTickers

CMRX: Chimerix, Inc. 2021-11-04 07:00:00 Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma

RocketTickers

IFRX: InflaRx N.V. 2021-10-27 07:30:00 InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum

RocketTickers

PGEN: Precigen, Inc. 2021-10-26 08:05:00 Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors

RocketTickers

MRK: Merck & Co., Inc. 2021-10-25 06:45:00 Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1 Infection

RocketTickers

MRNA: Moderna, Inc. 2021-10-25 08:30:00 Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age